Source: The Business Journals: Philadelphia

Onconova Therapeutics: In need of cash, longtime Bucks County biotech firm enters into merger deal

Onconova posted a net loss of $18.9 million in 2023. Since its inception, the company has an accumulated deficit of $482.6 million.

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Steven M. Fruchtman's photo - President & CEO of Onconova Therapeutics

President & CEO

Steven M. Fruchtman

CEO Approval Rating

90/100

Read more